KRSNAA

What Krsnaa Diagnostics promised, and what happened

Every commitment management made on a call, tracked from the quarter it was made — reaffirmed, revised, diluted or quietly dropped.

Guidance record · Q1 FY27

what the last two calls moved 16 tracked 1 delivered 5 missed 10 open
  • Retail Revenue Share delivered said Q4 FY25 Promised: 5% to 8% in FY26 Q1 FY27: Promise deadline has passed.
  • FY25 Revenue Growth missed said Q3 FY25 Promised: 25% YoY growth for FY25 Q1 FY27: Promise deadline has passed.
  • Retail Segment Profitability went quiet said Q1 FY26 Promised: Breakeven by the end of FY26 Q1 FY27: New target for Retail Pathology Labs (RPL) to be EBITDA positive by Q2 FY27. Q1 was EBITDA negative due to manpower deployment.

The rest of the ledger

Above is what the last two calls moved. Pro opens all 16 tracked commitments for Krsnaa Diagnostics — every quarter's revision, the source quote behind each one, and the topics management has stopped answering.

See what Pro opens